ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 92 filers reported holding ASCENDIS PHARMA A/S in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $9,188,000 | -10.3% | 69,849 | -12.1% | 0.03% | -22.7% |
| Q1 2021 | $10,246,000 | -34.4% | 79,508 | -15.1% | 0.04% | -41.3% |
| Q4 2020 | $15,610,000 | +8.1% | 93,600 | 0.0% | 0.08% | +1.4% |
| Q3 2020 | $14,444,000 | +4.3% | 93,600 | 0.0% | 0.07% | -7.5% |
| Q2 2020 | $13,843,000 | +27.8% | 93,600 | -2.7% | 0.08% | +14.3% |
| Q1 2020 | $10,833,000 | -17.6% | 96,200 | +1.8% | 0.07% | +6.1% |
| Q4 2019 | $13,146,000 | +88.3% | 94,500 | +30.3% | 0.07% | +73.7% |
| Q3 2019 | $6,983,000 | -19.1% | 72,500 | -3.3% | 0.04% | -20.8% |
| Q2 2019 | $8,636,000 | -2.2% | 75,000 | 0.0% | 0.05% | -5.9% |
| Q1 2019 | $8,827,000 | -42.1% | 75,000 | -69.2% | 0.05% | -46.3% |
| Q4 2018 | $15,243,000 | -21.3% | 243,306 | -11.0% | 0.10% | -7.8% |
| Q3 2018 | $19,361,000 | -18.1% | 273,237 | -23.1% | 0.10% | -24.3% |
| Q2 2018 | $23,637,000 | +1.7% | 355,348 | 0.0% | 0.14% | +3.0% |
| Q1 2018 | $23,239,000 | +63.3% | 355,348 | 0.0% | 0.13% | +69.2% |
| Q4 2017 | $14,235,000 | +10.5% | 355,348 | 0.0% | 0.08% | +5.4% |
| Q3 2017 | $12,881,000 | – | 355,348 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |